Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05698823

Regular Home-use of Dual-light Photodynamic Therapy in the Management of Chronic Stage III-IV Periodontitis

Conditions: Periodontitis Chronic Generalized Moderate, Periodontitis Chronic Generalized Severe

Sex: All
Ages: 18 Years – 85 Years
Phase: NA
Enrollment: 60
Sponsor: Koite Health Oy

Location: Lithuania

Summary

This study is designed to determine the efficacy of the Lumoral method in chronic periodontitis with a targeted group of stage III and IV periodontitis.Improved supragingival plaque control can help to also sustain the subgingival plaque management in the long term.In addition, the method might have a photobiomodulation effect on periodontal tissues.

Eligibility Criteria

Inclusion Criteria:Periodontal disease stage III-IV, according to criteria the American Academy of Periodontology (AAP) with at least 3 mm interdental clinical attachment level (CAL) in the site of greatest loss.≥ 18 years oldPresence of ≥20 teeth, including implantsAgreement to participate in the study and to sign a written consent formAble to co-operate with the treatment protocol and avoid any other oral hygiene measures outside of the study protocolExclusion Criteria:Grade A or C periodontitisPresence of any physical limitation or restriction that might restrict Lumoral usePregnancy or lactationActive smokingMedicated diabetes mellitus (DM)Any systemic disease (e.g., wound healing dysfunctions) that could alter the progression of periodontal diseaseUse of antibiotics within 4 weeks week prior studyPeriodontal treatment within 3 months prior studyRemovable major prosthesis or major orthodontic applianceA need for a hopeless teeth extraction, or open cavities in need for immediate endodontic treatment

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05698823). StuddyBuddy aggregates publicly available trial information.